These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In the crossfire: Collins on genomes, patents, and 'rivalry'. Interview by Eliot Marshall, Elizabeth Pennisi, and Leslie Roberts. Collins F Science; 2000 Mar; 287(5462):2396-8. PubMed ID: 10766612 [No Abstract] [Full Text] [Related]
3. Intellectual property rights. Public sector collaboration for agricultural IP management. Atkinson RC; Beachy RN; Conway G; Cordova FA; Fox MA; Holbrook KA; Klessig DF; McCormick RL; McPherson PM; Rawlings HR; Rapson R; Vanderhoef LN; Wiley JD; Young CE Science; 2003 Jul; 301(5630):174-5. PubMed ID: 12855794 [No Abstract] [Full Text] [Related]
4. Genomics. Public-private project to deliver mouse genome in 6 months. Marshall E Science; 2000 Oct; 290(5490):242-3. PubMed ID: 11183365 [TBL] [Abstract][Full Text] [Related]
6. Human genome. Finally, the book of life and instructions for navigating it. Pennisi E Science; 2000 Jun; 288(5475):2304-7. PubMed ID: 10917823 [TBL] [Abstract][Full Text] [Related]
8. The human genome. Controversial from the start. Roberts L Science; 2001 Feb; 291(5507):1182-8. PubMed ID: 11233424 [No Abstract] [Full Text] [Related]
9. Science and the law. Working through the patent problem. Walsh JP; Cohen WM; Arora A Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928 [No Abstract] [Full Text] [Related]
10. The company that genome researchers love to hate. Marshall E Science; 1994 Dec; 266(5192):1800-2. PubMed ID: 7997873 [No Abstract] [Full Text] [Related]
11. In pursuit of patents: 21st century challenges. Blatt RJ J Biolaw Bus; 1998; 1(4):4-7. PubMed ID: 11657745 [No Abstract] [Full Text] [Related]
12. Sequence interpretation. Functional annotation of mouse genome sequences. Nadeau JH; Balling R; Barsh G; Beier D; Brown SD; Bucan M; Camper S; Carlson G; Copeland N; Eppig J; Fletcher C; Frankel WN; Ganten D; Goldowitz D; Goodnow C; Guenet JL; Hicks G; Hrabe de Angelis M; Jackson I; Jacob HJ; Jenkins N; Johnson D; Justice M; Kay S; Kingsley D; Lehrach H; Magnuson T; Meisler M; Poustka A; Rinchik EM; Rossant J; Russell LB; Schimenti J; Shiroishi T; Skarnes WC; Soriano P; Stanford W; Takahashi JS; Wurst W; Zimmer A; Science; 2001 Feb; 291(5507):1251-5. PubMed ID: 11233449 [No Abstract] [Full Text] [Related]
13. How a bland statement sent stocks sprawling. Marshall E Science; 2000 Mar; 287(5461):2127. PubMed ID: 10744525 [No Abstract] [Full Text] [Related]
14. Genomic capital: public cultures and market logics of corporate biotechnology. Rajan KS Sci Cult (Lond); 2003 Mar; 12(1):87-121. PubMed ID: 15971369 [No Abstract] [Full Text] [Related]
15. Critics challenge Celera's claims over human genome sequence...as biotech debate splits along party lines. Smaglik P Nature; 2000 Apr; 404(6779):691-2. PubMed ID: 10783855 [No Abstract] [Full Text] [Related]
16. The role of the private sector in biotechnology: research and development. Feisee L Health Matrix Clevel; 2002; 12(2):357-65. PubMed ID: 12430359 [No Abstract] [Full Text] [Related]
17. Bermuda rules: community spirit, with teeth. Marshall E Science; 2001 Feb; 291(5507):1192. PubMed ID: 11233433 [No Abstract] [Full Text] [Related]
18. Genomic sequence information should be released immediately and freely in the public domain. Bentley DR Science; 1996 Oct; 274(5287):533-4. PubMed ID: 8928006 [No Abstract] [Full Text] [Related]
19. DNA sequencing. Genome teams adjust to shotgun marriage. Marshall E Science; 2001 Jun; 292(5524):1982-3. PubMed ID: 11408628 [No Abstract] [Full Text] [Related]